Real-time enrollment status for this alk positive non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 6:13 PM UTC
| NCT Number | NCT07617337 |
| Recruiting Status | Recruiting |
| Condition | ALK Positive Non-small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 102 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Chugai Pharmaceutical |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07617337 is currently recruiting participants. This phase1 study for alk positive non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Chugai Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07617337 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07617337 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.